For: |
He LJ, Yu YM, Qiao F, Liu JS, Sun XF, Jiang LL. Genetic polymorphisms of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i27/4268.htm |
Number | Citing Articles |
1 |
Chi-Chou Huang, Wen-Pin Chien, Ruey-Hong Wong, Ya-Wen Cheng, Meng-Cheng Chen, Ming-Chih Chou, Huei Lee. NAT2 Fast Acetylator Genotype is Associated with an Increased Risk of Colorectal Cancer in Taiwan. Diseases of the Colon & Rectum 2007; 50(7): 981 doi: 10.1007/s10350-007-0230-9
|
2 |
Amjad Mahasneh, Amal Jubaili, Ahmed El Bateiha, Mohammad Al-Ghazo, Ismail Matalka, Mousa Malkawi. Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer. Genetics and Molecular Biology 2012; 35(4): 725 doi: 10.1590/S1415-47572012005000074
|
3 |
Saba Kabir, Abdul Rehman. Carcinogenic potential of arylamine N-acetyltransferase in Asian populations. Journal of Cancer Research and Practice 2018; 5(4): 131 doi: 10.1016/j.jcrpr.2018.07.001
|
4 |
Ana C.T. Guilhen, Natassia E. Bufalo, Elaine C. Morari, Janaina L. Leite, Ligia V.M. Assumpcao, Alfio J.A. Tincani, Laura S. Ward. Role of the N-Acetyltransferase 2 Detoxification System in Thyroid Cancer Susceptibility. Clinical Cancer Research 2009; 15(1): 406 doi: 10.1158/1078-0432.CCR-08-1835
|
5 |
Bente A. Talseth, Cliff Meldrum, Janina Suchy, Grzegroz Kurzawski, Jan Lubinski, Rodney J. Scott. Genetic Polymorphisms in Xenobiotic Clearance Genes and Their Influence on Disease Expression in Hereditary Nonpolyposis Colorectal Cancer Patients. Cancer Epidemiology, Biomarkers & Prevention 2006; 15(11): 2307 doi: 10.1158/1055-9965.EPI-06-0040
|
6 |
Yan Wei Zhang, Sang‐Yong Eom, Yong‐Dae Kim, Young‐Jin Song, Hyo‐Yung Yun, Joo‐Seung Park, Sei‐Jin Youn, Byung Sik Kim, Heon Kim, David W. Hein. Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans. International Journal of Cancer 2009; 125(1): 139 doi: 10.1002/ijc.24328
|
7 |
Anahita Torkaman‐Boutorabi, Mahmood Hoormand, Naser Naghdi, Masoomeh Bakhshayesh, Iraj Milanian. GENOTYPE AND ALLELE FREQUENCIES OF N‐ACETYLTRANSFERASE 2 AND GLUTATHIONE S‐TRANSFERASE IN THE IRANIAN POPULATION. Clinical and Experimental Pharmacology and Physiology 2007; 34(11): 1207 doi: 10.1111/j.1440-1681.2007.04753.x
|
8 |
Bente A. Talseth-Palmer, Juul T. Wijnen, Desma M. Grice, Rodney J. Scott. Genetic modifiers of cancer risk in Lynch syndrome: a review. Familial Cancer 2013; 12(2): 207 doi: 10.1007/s10689-013-9614-2
|
9 |
Brian Tomlinson, Miao Hu, Vivian W. Y. Lee. In vivo assessment of herb–drug interactions: Possible utility of a pharmacogenetic approach?. Molecular Nutrition & Food Research 2008; 52(7): 799 doi: 10.1002/mnfr.200700454
|
10 |
Katy Walker, Gary Ginsberg, Dale Hattis, Douglas O. Johns, Kathryn Z. Guyton, Babasaheb Sonawane. Genetic Polymorphism inN-Acetyltransferase (NAT): Population Distribution of NAT1 and NAT2 Activity. Journal of Toxicology and Environmental Health, Part B 2009; 12(5-6): 440 doi: 10.1080/10937400903158383
|
11 |
Lou qian Zhang, Jian nong Zhou, Jun Wang, Guo dong Liang, Jing ying Li, Yi dan Zhu, Yun tao Su, Ludmila Prokunina-Olsson. Absence of Association between N-Acetyltransferase 2 Acetylator Status and Colorectal Cancer Susceptibility: Based on Evidence from 40 Studies. PLoS ONE 2012; 7(3): e32425 doi: 10.1371/journal.pone.0032425
|
12 |
Aung K. Win, Rodney J. Scott. Hereditary Colorectal Cancer. 2018; : 67 doi: 10.1007/978-3-319-74259-5_5
|